Search results
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Zacks via Yahoo Finance· 20 hours agoFDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of...
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
Benzinga· 1 day agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) ...
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application...
The Pilot News· 1 day agoViehbacher, "Biogen") announced today that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Supplemental Biologics License ...
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
InvestorPlace· 5 days agoPharma stocks have two unique characteristics that can make them great investments for many...
Alzheimer's drug that can slow disease gets backing from FDA advisers
WCSH 6 Portland· 13 hours agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
Japanese Market Modestly Higher
RTT News· 7 hours agoAdding to the gains in the previous session, the Japanese stock market is modestly higher on Tuesday, with the Nikkei 225 moving well above the 39,100 level, following the mixed cues from Wall ...
Making it easier to fly more than one airline to your destination - The Boston Globe
The Boston Globe· 4 days agoAccording to a Thursday notice from the US Consumer Product Safety Commission, Good Earth Lighting’s...
